A Phase I Clinical Study Trial of Felbinac Trometamol Injection in China
Clinical trial NCT03617510 · COMPLETED
Trial details
- NCT number
- NCT03617510
- Sponsor
- Shijiazhuang Yiling Pharmaceutical Co. Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-10
- Primary completion
- 2018-11-05
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.